{
  "id": 1533988,
  "title": "Monday 8/17 Insider Buying Report: ABCL, BPRN",
  "url": "https://urgent.news/2026/08/17/monday-8-17-insider-buying-report-abcl-bprn",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-17T17:52:58.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/monday-8-17-insider-buying-report-abcl-bprn"
  },
  "original_language": "en",
  "account": null,
  "summary": "As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At AbCellera Biologics, a filing with the SEC revealed that on Wednesday, Director",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}